Solutions that enable ablative radiotherapy for large liver tumors: Fractionated dose painting, simultaneous integrated protection, motion management, and computed tomography image guidance.
about
Significant symptoms alleviation and tumor volume reduction after combined simultaneously integrated inner-escalated boost and volumetric-modulated arc radiotherapy in a patient with unresectable bulky hepatocellular carcinoma: A care-compliant caseManagement of unresectable intrahepatic cholangiocarcinoma: how do we decide among the various liver-directed treatments?Excellent local control and tolerance profile after stereotactic body radiotherapy of advanced hepatocellular carcinoma.Local therapy reduces the risk of liver failure and improves survival in patients with intrahepatic cholangiocarcinoma: A comprehensive analysis of 362 consecutive patients.Dose escalation with an IMRT technique in 15 to 28 fractions is better tolerated than standard doses of 3DCRT for LAPC.Cholangiocarcinoma - evolving concepts and therapeutic strategies.Another solution that enables ablative radiotherapy for large liver tumors: Percutaneous interstitial high-dose rate brachytherapy.Evaluation of respiratory motion-corrected cone-beam CT at end expiration in abdominal radiotherapy sites: a prospective study.The role of imaging in the clinical practice of radiation oncology for pancreatic cancer.Evaluation of the tumor movement and the reproducibility of two different immobilization setups for image-guided stereotactic body radiotherapy of liver tumors.Systemic and Adjuvant Therapies for Intrahepatic Cholangiocarcinoma.Definitive radiation therapy for hepatocellular carcinoma with portal vein tumor thrombus.Non-surgical management of patients with intrahepatic cholangiocarcinoma in the United States, 2004-2015: an NCDB analysis.Proton beam therapy in apneic oxygenation treatment of an unresectable hepatocellular carcinoma: A case report and review of literature
P2860
Q33590673-ACAE5D66-08E6-4ECA-A236-41EDCF8D80A9Q33621522-EC075F73-77F9-421E-991C-D3309AED0586Q40137729-5BA87491-329C-48AD-A770-6E10B44C7B64Q40421102-DACB3542-7B22-4409-B6E5-4FA494B3A36CQ43379696-8CAB24B3-E3BE-407D-813D-6368E78BD8EBQ46087686-5945441E-5B8D-4429-BABB-9CD4F6733C60Q46171984-A4296755-6907-4330-A528-AF4278E9BB88Q47652912-BC5B9F92-147D-4C7C-A349-8AF14F5E0727Q48354898-6EDD72DB-E8E3-4617-BD1F-D6A22E2DB694Q49599453-45950CC4-AF20-4797-BA13-ABEA89862C0BQ49627919-62ABAB50-6BA2-4AFC-AF3E-A14682A561B0Q52624083-6365D892-6A59-48CA-9560-4B676DE93F00Q55618410-BC91F059-5D89-43A8-812B-67849AF8CC8CQ58603829-7C3D10B0-EF9E-48E9-BD10-2B56B589D53C
P2860
Solutions that enable ablative radiotherapy for large liver tumors: Fractionated dose painting, simultaneous integrated protection, motion management, and computed tomography image guidance.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 March 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Solutions that enable ablative ...... ted tomography image guidance.
@en
Solutions that enable ablative ...... ted tomography image guidance.
@nl
type
label
Solutions that enable ablative ...... ted tomography image guidance.
@en
Solutions that enable ablative ...... ted tomography image guidance.
@nl
prefLabel
Solutions that enable ablative ...... ted tomography image guidance.
@en
Solutions that enable ablative ...... ted tomography image guidance.
@nl
P2860
P356
P1433
P1476
Solutions that enable ablative ...... ted tomography image guidance.
@en
P2093
Christopher H Crane
Eugene J Koay
P2860
P304
P356
10.1002/CNCR.29878
P407
P577
2016-03-07T00:00:00Z